'Magic bullet' drug now available on clinical trial to breast cancer patients in Ireland

The treatment was found to increase by half the survival of patients with advanced breast cancers that have low levels of the HER2 protein. 

A new drug hailed as a “magic bullet” and “a new standard of care” is now available to breast cancer patients in Cork, Limerick, and Dublin hospitals as part of international clinical trials.

The treatment, which targets the cancer directly without affecting the body’s healthy cells, was found to increase by half the survival of patients with advanced breast cancers that have low levels of the HER2 protein.